The emergence of extensively drug-resistant strains of tuberculosis, especially in countries with a high prevalence of human immunodeficiency virus, is a serious threat to global public health and jeopardizes efforts to effectively control the disease. This publication offers updated recommendations for the diagnosis and management of drug-resistant tuberculosis in a variety of geographical, economic and social settings, and the recording of data that enables the monitoring and evaluation of programs.--Publisher's description.Patient data may be entered in a format similar to the Category IV Treatment Card , and lists similar to the Category IV Register ... 18.8 International health Regulations (IhR) The IHR (2005) entered into force on 15 June 2007 and are legallyanbsp;...
|Title||:||Guidelines for the Programmatic Management of Drug-resistant Tuberculosis|
|Author||:||Stop TB Initiative (World Health Organization)|
|Publisher||:||World Health Organization - 2008|